Invesco Ltd. - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 73 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$12,012,656
-27.0%
1,027,601
-16.1%
0.00%
-25.0%
Q2 2023$16,458,813
-12.5%
1,224,614
+7.9%
0.00%
-20.0%
Q1 2023$18,815,780
-29.7%
1,134,848
-21.1%
0.01%
-37.5%
Q4 2022$26,750,539
+40.8%
1,438,201
-2.9%
0.01%
+33.3%
Q3 2022$19,000,000
+184.3%
1,480,909
+55.4%
0.01%
+200.0%
Q2 2022$6,682,000
+70.2%
953,262
+101.3%
0.00%
+100.0%
Q1 2022$3,925,000
+1502.0%
473,497
+1206.2%
0.00%
Q4 2021$245,000
+17.2%
36,250
-8.2%
0.00%
Q3 2021$209,000
+5.6%
39,481
+14.9%
0.00%
Q2 2021$198,000
+38.5%
34,362
+10.5%
0.00%
Q1 2021$143,000
+20.2%
31,105
-12.7%
0.00%
Q4 2020$119,000
+41.7%
35,620
+25.8%
0.00%
Q3 2020$84,000
-56.7%
28,316
-32.4%
0.00%
Q2 2020$194,000
+74.8%
41,910
+44.6%
0.00%
Q1 2020$111,000
+44.2%
28,984
+40.2%
0.00%
Q4 2019$77,000
-96.3%
20,673
-94.8%
0.00%
-100.0%
Q3 2019$2,094,000
+4173.5%
394,346
+1437.3%
0.00%
Q4 2018$49,000
-51.5%
25,652
-3.6%
0.00%
Q3 2018$101,000
+13.5%
26,598
-6.9%
0.00%
Q2 2018$89,000
-91.2%
28,558
-93.1%
0.00%
Q4 2015$1,014,000
-18.1%
413,770
+0.2%
0.00%
-100.0%
Q3 2015$1,238,000
+20533.3%
412,753
+29766.4%
0.00%
Q2 2015$6,000
-96.5%
1,382
-97.9%
0.00%
Q2 2014$171,00067,3930.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 252,199$749,0002.35%
MANGROVE PARTNERS IM, LLC 3,031,965$9,005,0001.14%
ARMISTICE CAPITAL, LLC 10,000,000$29,700,0001.08%
GABLES CAPITAL MANAGEMENT INC. 432,864$1,286,0000.83%
Worth Venture Partners, LLC 268,682$798,0000.66%
XTX MARKETS LLC 18,749$56,0000.27%
Capital Impact Advisors, LLC 203,133$603,0000.18%
Wealthspire Advisors, LLC 337,770$1,003,0000.06%
ROYCE & ASSOCIATES LP 1,784,890$5,301,0000.06%
XML Financial, LLC 40,000$119,0000.04%
View complete list of CATALYST PHARMACEUTICALS INC shareholders